India bumps certifications to national level

Prompted by WHO concerns, Indian drug makers will begin approaching national regulatory authorities rather than state administrators to get facilities and export products certified. The switch, effective next month, is an attempt to streamline the regulatory process for pharmaceutical exports, but some expect it to add delays. Article

Sponsored By Digital Pharma Europe

Fierce Pharma Marketing is excited to announce the first virtual Digital Pharma Europe!

This summit will profile best-in-class case studies and senior-level discussions from leaders who are innovating the way we look at the intersection of digital technologies and marketing in Europe.